THE ROLE OF ETOPOSIDE (VP-16) IN PREPARATORY REGIMENS FOR PATIENTS WITH LEUKEMIA UNDERGOING ALLOGENEIC BONE MARROW TRANSPLANTATION
摘要
In 1983,we began a series of five clinical trials with the goal of reducing the relapse rate following
-
1Jin ZHANG Yan LIU.HER2 over-expression and response to different chemotherapy regimens in breast cancer[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2008,9(1):5-9. 被引量：3
-
2曹履先.供者淋巴细胞输注的临床应用[J].白血病．淋巴瘤,2001,10(4):197-198. 被引量：6
-
3赵艳霞,程晶.乳腺癌根治术后放射治疗适应证、部位及技术的研究进展[J].中华乳腺病杂志（电子版）,2013,7(4):28-33. 被引量：12
-
4EACopelan,BBolwell,JLKlien,NKapoor,BRAvalos.A NOVEL PREPARATORY REGIMEN INCLUDING BUSULFAN, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR AUTOLOGOUS TRANSPLANTATION IN HODGKIN AND NON-HODGKIN LYMPHOMA AND MULTIPLE MYELOMA[J].Chinese Medical Journal,1994(10):8-8.
-
5DPLu,NLGuo,XJHuang,JZhang,YMFan,QShi,BJiang.APPLICATION OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (FILGRASTIM) FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION[J].Chinese Medical Journal,1994(10):19-20.
-
6张琳,殷丽萍,高洋,韩美园,陆超.EL4T淋巴细胞白血病／淋巴瘤小鼠急性移植物抗宿主病动物模型的建立[J].中华实用儿科临床杂志,2013,28(3):183-187. 被引量：1
-
7杨学宁,吴一龙.四个第三代含铂联合化疗方案在晚期非小细胞肺癌中的比较[J].循证医学,2003,3(2):94-97. 被引量：4
-
8周彩存,钟文昭.吉西他滨联合铂类与其他含铂方案治疗晚期非小细胞肺癌的疗效比较:关于生存结果的荟萃分析[J].循证医学,2005,5(3):143-146. 被引量：70
-
9车利,邸立军,宋国红,贾军,余靖,王小利,祝毓琳,姜晗肪,梁旭.Gemcitabine Based Combination Regimens for Treatment of Refractory Advanced Breast Cancer[J].Chinese Journal of Cancer Research,2008,20(3):194-201.
-
10王存邦,白海,葸瑞,潘耀柱,张茜,周进茂,吴涛,徐淑芬.混合造血干细胞移植联合DLI-IL-2治疗急性髓性白血病的疗效[J].中国肿瘤生物治疗杂志,2011,18(1):55-58. 被引量：1
